Skip to main content
Research Priorities

Setting the Research Priorities for Hypertension

The British and Irish Hypertension Society (BIHS), in partnership with the British Heart Foundation Clinical Research Collaborative (BHF CRC), recently conducted an online workshop to identify help the Top 10 research questions most vital to improving hypertension management and care.

Following the Delphi approach of the James Lind Alliance, we engaged patients, carers, healthcare professionals and researchers in a series of surveys, narrowing down an extensive list of topics to focus on the most pressing questions. This collaborative event brought together 23 individuals, including patients and carers personally affected by hypertension, alongside experts.

Participants shared diverse perspectives, shaping a priority list that represents some of the urgent needs of those impacted by hypertension. These 10 questions will now help shape our future research priorities, ensuring studies are patient-centred, impactful, and practical for real-world health improvements.

Moving forward, the BIHS will further refine these priorities, collaborating more widely to address broader questions and ensure that future research directly enhances patient care and blood pressure management.

Stay connected as we develop and share new research initiatives designed to make meaningful progress in hypertension care. We welcome comments from our community to contribute and enrich the activities.

 

 

  Top 10 research priorities 

  identified:

  1. Validity of cuffless blood pressure measurement devices
  2. Screening in socioeconomically deprived communities and ethnic minorities
  3. Effective ways to enhance adherence to hypertension treatment
  4. Anti-hypertensive treatment's protective effect against cognitive impairment
  5. Impact of GLP1 receptor agonists on blood pressure control
  6. Outcome benefits associated with antihypertensive treatment
  7. Benefits of blood pressure treatment in the very elderly
  8. Office vs. home blood pressure guided treatment outcomes
  9. Baseline cardiovascular risk levels predicting treatment benefit
  10. Optimal BP treatment targets for home and ambulatory BP